<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, and Biological Products for Treatment; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, and Biological Products for Treatment; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2018-08-23 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, and Biological Products for Treatment." The purpose of this draft guidance is to assist sponsors who are developing drugs, devices, or biological products to treat the underlying pathophysiology and structural progression of osteoarthritis (OA). This draft guidance does not address improvement of sym...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2018-18214</p>
    <p><strong>Publication Date:</strong> 2018-08-23</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2018/08/23/2018-18214/osteoarthritis-structural-endpoints-for-the-development-of-drugs-devices-and-biological-products-for">https://www.federalregister.gov/documents/2018/08/23/2018-18214/osteoarthritis-structural-endpoints-for-the-development-of-drugs-devices-and-biological-products-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2018-18214</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
